Collectively, these results above indicated that PM could induce the lower expression of PD-L1 protein through AMPK signaling activation with a far lower dose compared with its analog metformin both in mice and human cancer cells (Fig. 1; Additional file 1: Fig. S2). Here, CD274 is linked to cancer.